The Promise of T Cell Engineering
The Columbia Initiative in Cell Engineering and Therapy will host a symposium featuring recent advances in T cell genome editing and a sampling of upcoming cell therapy clinical studies at VP&S in oncology, rheumatology and neurology.
Hosted by: Columbia Initiative in Cell Engineering and Therapy (CICET)
Host: Michel Sadelain, MD, PhD, Director, Columbia Initiative in Cell Engineering and Therapy
Keynote Speaker: Justin Eyquem, PhD
Associate Professor, Department of Medicine, University of California San Francisco
The symposium is open to all Columbia faculty, staff, and trainees.
